P018 Reintroducing Burosumab in Symptomatic Adult X-Linked Hypophosphataemic Rickets

P006 Treatment options if burosumab significantly improves symptoms related to X-linked hypophosphatemia but causes massive injection site reactions in adults
Rheumatology advances in practice1 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
P008 Bilateral Stress Fractures Revealing FGF23-Mediated Hypophosphatemia Rickets in an Adult with Co-existing Endocrine Disorders
Rheumatology advances in practice1 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Laboratory-based case finding using phosphate and alkaline phosphatase to identify genetic and nutritional rickets in children
Beatriz Domínguez-Sevillano, Mary Alejandra Ferrín-Ferrín, David Cembrero-Fuciños +7
Frontiers in endocrinology16 Oct 2026Peer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
Non-nutritional rickets: Approach, precision medicine, and outcomes
Pratyush Prateek Pathak, Sayantan Ray
World Journal of Clinical Pediatrics3 Nov 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
Burosumab-responsive micro tumor-induced osteomalacia caused by a 6-mm phosphaturic mesenchymal tumor of the femoral head: a case report with review of literature on small (≤10 mm) FGF23-producing tumors
Norio Horiguchi, Kenichiro Okuno, Mari Arai-Uehara +11
Endocrine Journal26 Sep 2026Peer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGE

Cite

BibTeX

@article{anon2026p018,
  title = {{P018 Reintroducing Burosumab in Symptomatic Adult X-Linked Hypophosphataemic Rickets}},
  journal = {Rheumatology advances in practice},
  year = {2026},
  month = nov,
  url = {https://europepmc.org/article/PMC/PMC13728561},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - P018 Reintroducing Burosumab in Symptomatic Adult X-Linked Hypophosphataemic Rickets
PY  - 2026
DA  - 2026/11/01
JO  - Rheumatology advances in practice
UR  - https://europepmc.org/article/PMC/PMC13728561
SN  - 2514-1775
ER  -

Related

Cite